The impact exerted by the severity of recreational drug abuse on the different components of the executive function;Impacto de la gravedad del consumo de drogas sobre distintos componentes de la función ejecutiva

Revista de Neurologia

Volumn 38, Issue 12, 2004, Pages 1109-1116

  Verdejo Garcia, Antonio J ^a   Orozco Gimenez C ^a   Meersmans Sanchez Jofre M ^a   Aguilar De Arcos, F ^a   Perez Garcia M ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Dorsolateral circuit; Executive functioning; Severity; Substance abuse; Ventromedial circuit

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE;

ADULT; ALCOHOL ABUSE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COCAINE DEPENDENCE; DISEASE SEVERITY; DRUG ABUSE; HEROIN DEPENDENCE; HUMAN; MALE; NEUROPSYCHOLOGY; SUBSTANCE ABUSE;

EID: 3543095619     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3812.2003592     Document Type: Article

References (50)

1. Verdejo A, López-Torrecillas F, Orozco C, Pérez- García M. Impacto de los deterioros neuropsicológicos asociados al consumo de drogas sobre la práctica clínica con sujetos drogodependientes. Adicciones 2002; 14: 345-70.
2. Tirapu J, Landa N, Lorea I. Sobre las recaídas, la mentira y la falta de voluntad de los adictos. Adicciones 2002; 15: 10-6.
3. Teichner G, Horner MD, Roitzsch JC, Herron J, Thevos A. Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addict Behav 2002; 27: 751-63.
4. Aharonovic E, Nunes E, Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend 2003; 71: 207-11.
5. Damasio AR. Descartes' error: emotion, reason, and the human brain. New York: Grosset/Putnam; 1994.
6. Lezak MD. Neuropsychological assessment. 3 ed. New York: Oxford University Press; 1995.
7. Pineda DA. La función ejecutiva y sus trastornos. Rev Neurol 2000; 30: 764-8.
8. Roberts AC, Robbins TW, Weiskrantz L. The prefrontal cortex: executive and cognitive functions. London: Oxford University Press; 1998.
9. Stuss DT, Alexander MP. Executive functions and the frontal lobes: a conceptual view. Psychol Res 2000; 63: 289-98.
10. Barkley RA. The executive functions and self-regulation: an evolutionary neuropsychological perspective. Neuropsychol Rev 2001; 11: 1-29.
11. Baddeley A. The central executive: A concept and some misconceptions. J Int Neuropsychol Soc 1998; 4: 523-6.
12. Miyake A, Friedman NP, Emerson MJ, Witzky AH, Howerther A. The unity and diversity of executive function and their contribution to complex frontal lobe tasks: a latent variable analysis. Cognit Psychol 2000; 41: 49-100.
13. Denckla MB. A theory and model of executive function: a neuropsychological perspective. In Lyon GR, Krasnegor NA, eds. Attention, memory, and executive functions. Baltimore: PH Brookes; 1996. p. 117-42.
14. Goldberg E. The executive brain: frontal lobes and the civilized mind. New York: Oxford University Press; 2001.
15. Shallice T, Burgess P. The domain of supervisory processes and temporal organization of behavior. Philos Trans R Soc Lond B Biol 1996; 351: 1405-11.
16. Bechara A, Damasio H, Damasio AR. Emotion, decision-making and the orbitofrontal cortex. Cereb Cortex 2000; 10: 295-307.
17. Cummings JL. Frontal subcortical circuits and human behavior. Arch Neurol 1993; 50: 873-80.
18. Bechara A, Damasio H, Damasio AR, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994; 50: 7-15.
19. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychology 2001; 39: 376-89.
20. Goldberg E, Podell K. Adaptative decision-making, ecological validity, and the frontal lobes. J Clin Exp Psychol 2000; 22: 56-68.
21. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 1999; 20: 322-39.
22. López-Torrecillas F, Martín I, De La Fuente I, Godoy J. Estilo atribucional, autocontrol y asertividad como predictores de la gravedad del consumo de drogas. Psicothema 2000; 12: 323-5.
23. López-Torrecillas F, Godoy JF, Pérez-Garcia M, Godoy D, Sánchez-Barrera M. Variables modulating stress and coping that discriminate drug consumers from low or not drug consumers. Addict Behav 2001; 25: 161-5.
24. Ruff RM. Ruff figural fluency test: professional manual. Florida: Psychological Assessment Resources; 1996.
25. Wechsler D. Wechsler adult intelligence scale. 3 ed. San Antonio, TX: The Psychological Corporation; 1997 [Edición española, Madrid: TEA; 1999.]
26. Baddeley AD, Hitch G. Working memory. In Bowler GA, ed. The psychology of learning and motivation. Vol 8. New York: Academic Press; 1974. p. 47-89.
27. Sedo M, Levenson R. Culture free five-minute testing of higher mental processes. Annual Meeting of the International Association for Cross-Cultural Psychology. Pamplona, España; 1994.
28. DeFilippis NA. Category test: computer version research edition. Florida: Psychological Assessment Resources; 2002.
29. Bolla KI, Funderburk FR, Cadet JL. Differential effects of cocaine and cocaine + alcohol on neurocognitive performance. Neurology 2000; 54: 2285-92.
30. Morgan MJ, McFie L, Fleetwood LH, Robinson JA. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 2002; 159: 294-303.
31. Ornstein TJ, Iddon JL, Baldacchino AM, Sahaldan BJ, London M, Everitt BJ, et al. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacol 2000; 23: 113-26.
32. Rogers RD, Robbins TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 2001; 11: 250-7.
33. Roselli M, Ardila A. Cognitive effects of cocaine and polydrug abuse. J Clin Exp Neuropsychol 1996; 18: 122-35.
34. Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, et al. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychol Res 2000; 98: 93-102.
35. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642-52.
36. Ricaurte GA, Finnegan KT, Irwin I, Langston JW. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations. Ann N Y Acad Sci 1990; 600: 699-710.
37. Strickland TL, Miller BL, Kowell A, Stein R. Neurobiology of cocaine-induced organic brain impairment: contributions from functional neuroimaging. Neuropsychol Rev 1998; 8: 1-8.
38. Grant S, Conttoreggi C, London ED. Drug abusers show impaired performance in a laboratory test of decision-making. Neuropsychol 2000; 38: 1180-7.
39. Bechara A, Damasio H. Decision-making and addiction (part 1): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychology 2002; 40: 1675-89.
40. Verdejo A, Aguilar de Arcos F, Sánchez-Barrera M, Pérez-García M. Deterioro de los procesos de toma de decisiones en una muestra de drogodependientes. In: Cerebro y adicciones. Madrid: Mapfre; 2003. p. 421-34.
41. Volkow ND, Fowler JS. Addiction: a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000; 10: 318-25.
42. Ernst M, Grant SJ, London ED, Kimes AS, Spurgeon L. Decision-making in adolescents with behavior disorders and adults with substance abuse. Am J Psychiatry 2003; 160: 33-40.
43. Bhattachary S, Powell JH. Recreational use of 3-4-methyle- dioxymethanphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment. Psychol Med 2001; 31: 647-58.
44. Liu X, Matochick JA, Cadet J, London ED. Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacol 1998; 18: 243-52.
45. Gerra G, Zaimovic A, Timpano M, Zambelli U, Begarani M, Marzocchi G, et al. Neuroendocrine correlates of temperament traits in abstinent opiate addicts. J Subst Abuse 2000; 11: 337-54.
46. Sedo M, DeCristoforo L, Lang JA. '5 digit test': a multilinguistic non-reading alternative to the Stroop test. Boston, Mass: Scientific Fair of the Massachusetts Neuropsychological Association; 2003.
47. Petry NM, Casarella T. Excessive discounting of delayed rewards in substance abusers with gambling problems. Drug Alcohol Depend 1999; 56: 25-32.
48. Fillmore MT, Rush CR. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend 2002; 66: 265-73.
49. Fillmore MT, Rush CR, Hays L. Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend 2002; 67: 157-67.
50. Cowan RL, Lio I, Mo Sung S, Heup Ahn K, Kim MJ, Hwang J, et al. Reduced cortical gray matter density in human MDMA (ecstasy) users: a voxel based volumetry study. Drug Alcohol Depend 2003; 72: 225-35.